Novel immunotherapy vaccine development

M Jutel, CA Akdis - Current Opinion in Allergy and Clinical …, 2014 - journals.lww.com
M Jutel, CA Akdis
Current Opinion in Allergy and Clinical Immunology, 2014journals.lww.com
The cloning of allergen proteins and genetic engineering enabled the production of
vaccines that have well defined molecular, immunologic and biologic characteristics as well
as modified molecular structure. These new compounds along with new immunization
protocols can bring us closer to the ultimate goal of AIT, that is, complete cure of a large
number of allergic patients.
Summary
The cloning of allergen proteins and genetic engineering enabled the production of vaccines that have well defined molecular, immunologic and biologic characteristics as well as modified molecular structure. These new compounds along with new immunization protocols can bring us closer to the ultimate goal of AIT, that is, complete cure of a large number of allergic patients.
Lippincott Williams & Wilkins